Zurich Cantonal Bank
IART icon

Zurich Cantonal Bank’s Integra LifeSciences IART Stock Holding History

Zurich Cantonal Bank’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$271K Buy
+28,785
New +$316K ﹤0.01% 2139
2025
Q4 		– Sell
-19,014
Closed -$253K – 2999
2025
Q3 		$272K Hold
19,014
– – ﹤0.01% 2047
2025
Q2 		$233K Buy
19,014
+2,203
+13% +$32K ﹤0.01% 2059
2025
Q1 		$370K Buy
16,811
+2,357
+16% +$55.4K ﹤0.01% 1779
2024
Q4 		$328K Hold
14,454
– – ﹤0.01% 1881
2024
Q3 		$263K Hold
14,454
– – ﹤0.01% 1962
2024
Q2 		$421K Buy
14,454
+1,010
+8% +$30K ﹤0.01% 1604
2024
Q1 		$477K Sell
13,444
-2,724
-17% -$109K ﹤0.01% 1486
2023
Q4 		$704K Buy
16,168
+1,896
+13% +$74.6K ﹤0.01% 1271
2023
Q3 		$545K Buy
14,272
+1,946
+16% +$81.9K ﹤0.01% 1340
2023
Q2 		$507K Buy
12,326
+674
+6% +$32.4K ﹤0.01% 1338
2023
Q1 		$669K Buy
11,652
+1,547
+15% +$87.2K ﹤0.01% 1123
2022
Q4 		$567K Buy
10,105
+804
+9% +$40.9K ﹤0.01% 1182
2022
Q3 		$394K Buy
9,301
+943
+11% +$48.3K ﹤0.01% 1346
2022
Q2 		$452K Sell
8,358
-1,316
-14% -$79K ﹤0.01% 1289
2022
Q1 		$622K Sell
9,674
-1,588
-14% -$105K ﹤0.01% 1212
2021
Q4 		$754K Buy
11,262
+4,283
+61% +$290K ﹤0.01% 1168
2021
Q3 		$478K Hold
6,979
– – ﹤0.01% 1329
2021
Q2 		$476K Sell
6,979
-513
-7% -$36.3K ﹤0.01% 1256
2021
Q1 		$518K Sell
7,492
-1,133
-13% -$76.8K ﹤0.01% 1210
2020
Q4 		$560K Buy
8,625
+670
+8% +$36.1K ﹤0.01% 1217
2020
Q3 		$376K Hold
7,955
– – ﹤0.01% 1222
2020
Q2 		$374K Buy
7,955
+1,772
+29% +$87.1K ﹤0.01% 1156
2020
Q1 		$276K Buy
6,183
+849
+16% +$44.6K ﹤0.01% 1073
2019
Q4 		$311K Buy
5,334
+753
+16% +$44.8K ﹤0.01% 1102
2019
Q3 		$275K Buy
4,581
+360
+9% +$21.4K ﹤0.01% 1095
2019
Q2 		$236K Hold
4,221
– – ﹤0.01% 1156
2019
Q1 		$235K Sell
4,221
-850
-17% -$43.3K ﹤0.01% 1120
2018
Q4 		$229K Buy
5,071
+412
+9% +$22.6K ﹤0.01% 1133
2018
Q3 		$307K Buy
4,659
+310
+7% +$19.3K ﹤0.01% 1080
2018
Q2 		$280K Buy
4,349
+543
+14% +$33.6K ﹤0.01% 1076
2018
Q1 		$211K Hold
3,806
– – ﹤0.01% 1168
2017
Q4 		$182K Buy
3,806
+1,054
+38% +$51.6K ﹤0.01% 1238
2017
Q3 		$139K Hold
2,752
– – ﹤0.01% 1194
2017
Q2 		$150K Buy
2,752
+218
+9% +$10.4K ﹤0.01% 1125
2017
Q1 		$107K Buy
2,534
+968
+62% +$41.4K ﹤0.01% 1303
2016
Q4 		$67K Hold
1,566
– – ﹤0.01% 1540
2016
Q3 		$65K Buy
1,566
+240
+18% +$10.1K ﹤0.01% 1500
2016
Q2 		$53K Hold
1,326
– – ﹤0.01% 1470
2016
Q1 		$45K Hold
1,326
– – ﹤0.01% 1484
2015
Q4 		$45K Buy
1,326
+416
+46% +$13K ﹤0.01% 1504
2015
Q3 		$27K Buy
910
+678
+292% +$21.2K ﹤0.01% 1402
2015
Q2 		$6K Hold
232
– – ﹤0.01% 1759
2015
Q1 		$6K Buy
+232
New +$5.48K ﹤0.01% 1730
2013
Q4 		– Sell
-97,859
Closed -$1.61M – 986
2013
Q3 		$1.61M Hold
97,859
– – 0.06% 353
2013
Q2 		$1.47M Buy
+97,859
New +$1.43M 0.05% 335

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Zurich Cantonal Bank's IART Position: Q1 2026 in Review

Zurich Cantonal Bank opened a new position in Integra LifeSciences (IART) in Q1 2026: 28,785 shares worth $271K. The stake represents ﹤0.01% of the portfolio and ranks #2139 among its holdings. This is a return to the name: Zurich Cantonal Bank previously reported a position in IART as recently as Q3 2025.

Zurich Cantonal Bank first reported a position in IART in Q2 2013 and has held it in 46 quarters since. The position peaked at $1.61M in Q3 2013. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

  • Zurich Cantonal Bank held 28,785 shares of Integra LifeSciences worth $271K as of Q1 2026.
  • Integra LifeSciences was a new Zurich Cantonal Bank position in Q1 2026.
  • Integra LifeSciences made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q1 2026, its #2139 holding.
  • Zurich Cantonal Bank first reported a position in Integra LifeSciences in Q2 2013 and has held it in 46 quarters since.
  • Zurich Cantonal Bank's Integra LifeSciences position peaked at $1.61M in Q3 2013.
  • 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.